                         SEQUENCE LISTING

<110>  NEXIMMUNE, INC.
 
<120>  CELL COMPOSITIONS COMPRISING ANTIGEN-SPECIFIC T CELLS FOR 
       ADOPTIVE THERAPY

<130>  NEX-010

<150>  62/561,044
<151>  2017-09-20

<150>  62/656,679
<151>  2018-04-12

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  1

Arg Met Phe Pro Asn Ala Pro Tyr Leu 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  2

Cys Met Thr Trp Asn Gln Met Asn Leu 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  3

Val Leu Asp Phe Ala Pro Pro Gly Ala 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  4

Ser Leu Gly Glu Gln Gln Tyr Ser Val 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  5

Val Leu Asp Gly Leu Asp Val Leu Leu 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  6

Asn Leu Thr His Val Leu Tyr Pro Val 
1               5                   


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  7

Ser Leu Tyr Ser Phe Pro Glu Pro Glu Ala 
1               5                   10  


<210>  8
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  8

Ala Leu Tyr Val Asp Ser Leu Phe Phe Leu 
1               5                   10  


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  9

Ser Leu Leu Gln His Leu Ile Gly Leu 
1               5                   


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  10

Glu Leu Thr Leu Gly Glu Phe Leu Lys Leu 
1               5                   10  


<210>  11
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  11

Leu Asp Arg Glu Arg Ala Lys Asn Lys Ile 
1               5                   10  


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  12

Phe Leu Asp Arg Phe Leu Ser Cys Met 
1               5                   


<210>  13
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  13

Ser Leu Ile Ala Ala Ala Ala Phe Cys Leu Ala 
1               5                   10      


